When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Lixte Biotechnology Holdings (LIXT) has filed to raise $10 million in an IPO of its common stock, according to an S-1 registration statement.
The firm is developing a pipeline of treatments for various types of cancers and vascular and metabolic diseases.
LIXT is outsourcing its clinical trials for its primary compound and likely intends to partner/license the drug upon successful completion of Phase 2 trials, an unusual approach.
I'll provide a final opinion when we learn more about the IPO from management.